(CBN News) Israel’s Institute for Biological Research (IIBR) will begin conducting human trials on its coronavirus vaccine by the end of the month.
Defense Minister Benny Gantz announced the progress after visiting the government-funded laboratory Monday night. He also met with Shmuel Shapira, the institute’s head.
“We are in a very significant moment. Prof. Shapira and the entire team did a fantastic job, they are the scientific frontier of the State of Israel and they have brought the vaccine to a stage where we can begin human trials soon,” Gantz said, adding that the vaccine will be called “Brilife.” The name comes from Hebrew. “Bri” is the Hebrew word for health, and “il” stands for “Israel” and “life.”